Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency

Clinical trial NCT07126288 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07126288
Sponsor: Shenzhen Kexing Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency in Children Growth Hormone Deficiency (GHD)Growth Hormone

Start date: 2025-08-31
Primary completion: 2028-09-15
Enrollment: 268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.